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Abstract
Background: Strains of Mycobacterium tuberculosis vary in virulence. Strains that have caused outbreaks in the United States
and United Kingdom have been shown to subvert the innate immune response as a potential immune evasion mechanism.
There is, however, little information available as to whether these patterns of immune subversion are features of individual
strains or characteristic of broad clonal lineages of M. tuberculosis.
Methods: Strains from two major modern lineages (lineage 2 [East-Asian] and lineage 4 [Euro-American]) circulating in the
Western Cape in South Africa as well as a comparator modern lineage (lineage 3 [CAS/Delhi]) were identified. We assessed
two virulence associated characteristics: mycobacterial growth (in liquid broth and monocyte derived macrophages) and
early pro-inflammatory cytokine induction.
Results: In liquid culture, Lineage 4 strains grew more rapidly and reached higher plateau levels than other strains (lineage 4
vs. lineage 2 p= 0.0024; lineage 4 vs. lineage 3 p= 0.0005). Lineage 3 strains were characterized by low and early plateau
levels, while lineage 2 strains showed an intermediate growth phenotype. In monocyte-derived macrophages, lineage 2
strains grew faster than lineage 3 strains (p,0.01) with lineage 4 strains having an intermediate phenotype. Lineage 2
strains induced the lowest levels of pro-inflammatory TNF and IL-12p40 as compared to other lineages (lineage 2: median
TNF 362 pg/ml, IL-12p40 91 pg/ml; lineage 3: median TNF 1818 pg/ml, IL-12p40 123 pg/ml; lineage 4: median TNF
1207 pg/ml, IL-12p40 205 pg/ml;). In contrast, lineage 4 strains induced high levels of IL-12p40 and intermediate level of
TNF. Lineage 3 strains induced high levels of TNF and intermediate levels of IL-12p40.
Conclusions: Strains of M. tuberculosis from the three major modern strain lineages possess distinct patterns of growth and
cytokine induction. Rapid growth and immune subversion may be key characteristics to the success of these strains in
different human populations.
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Introduction
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB),
infects over 2 billion people world-wide and causes 1.7 million
deaths annually [1]. The clinical significance of strain variation in
M. tuberculosis remains controversial, partly since virulence cannot
be simply defined in relation to defined virulence characteristics as
in other bacterial pathogens, such as Clostridium tetani or
Staphylococcus aureus. Since modern M. tuberculosis evolves through
single nucleotide substitutions, deletion and duplication events, the
population structure is strongly clonal [2]. It is therefore feasible
that such clonal lineages may evolve specific virulence character-
istics [3].
In a robust phylogenetic study based on genomic deletion
analysis, M. tuberculosis has been classified into six major lineages.
These lineages are highly predominant in specific geographic areas
and named according to their geographical distribution: Lineage 1
(also known as Indo-Oceanic lineage), Lineage 2 (also known as
East Asian; includes ‘‘Beijing’’), Lineage 3 (also known as CAS/
Delhi), Lineage 4 (also known as Euro-American), Lineage 5 (also
known as West African 1) and Lineage 6 (also known West African
2). In the Western Cape region of South Africa the ‘‘Lineage 2
(East Asian; includes ‘‘Beijing’’) and ‘‘Lineage 4 (Euro-American;
includes LAM3/F11 strains) lineages predominate [4,5,6,7].
Macrophages are the primary site of intracellular replication of
M. tuberculosis. In humans, large numbers of alveolar macrophages
are not readily available for in vitro study, therefore matured
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human monocyte derived macrophages (MDM) derived from
peripheral blood mononuclear cells (PBMC) are often used as an in
vitro model to study M. tuberculosis infection in human cells.
Activated macrophages in the presence of T cells and inflamma-
tory cytokines are known to be effective in restricting mycobac-
terial growth.
Lineage 2 strains are transmitted globally with a high tendency
to cause outbreaks and multidrug-resistant tuberculosis infection,
suggesting that this lineage may possess particular virulence
characteristics [8,9]. Recent reports indicate that lineage 2 strains
are emerging in Western Cape region of South Africa [10,11].
Lineage 2 strains replicate to high bacillary loads in lungs of
infected mice [12]. Strains from this genotype have been shown to
replicate more rapidly in the human cell culture model [13,14,15].
Several human and animal studies have suggested that the
propensity of lineage 2 strains to induce lower levels of protective
Th1 cytokines (such as TNF, IL-12 and IFN-c) may be, in part,
responsible for enhanced virulence [16,17,18,19,20].
Lineage 3 is related to lineage 2 by genome-based phylogeny [7]
but is more restricted in geographical location and largely confined
to the Indian subcontinent and some regions in East Africa that
have experienced a significant Indian migration. This lineage is
also common in the United Kingdom amongst Indian populations
[21] but is uncommon in Cape Town. Two studies have reported
that CAS (central Asian) strains, which belong to lineage 3, grow
slowly in liquid broth [19,22]. Furthermore, a lineage 3 strain
(CH), responsible for an outbreak in the United Kingdom,
induced less protective IL12p40 and more anti-inflammatory IL-
10 than the reference strain H37Rv [22].
Lineage 4 is distributed throughout Europe, America, parts of
Africa and the Middle East. This lineage includes Haarlem, Latin
American Mediterranean (LAM), X and T families of strains
[4,23]. Strains belonging to the LAM3 family, characterised by the
deletion RD761 (RD: region of differentiation) are common in
South Africa [2]. The reference strain H37Rv also belongs to
lineage 4. H37Rv grows well in the monocyte derived macrophage
model [24] and induces similar patterns of cytokines as Harlem
and LAM strains in human macrophages [20].
The above experimental evidence suggests that lineages of M.
tuberculosis may be characterised by lineage-specific patterns of
growth and cytokine induction. The aim of this study was to
determine whether strains of M. tuberculosis from the two major
circulating lineages in South Africa (lineage 2 and lineage 4)
demonstrate such lineage-specific characteristics in vitro models,
and whether such patterns are conserved amongst several
representatives of these lineages. We also wanted to compare
these patterns with those associated with representatives of the
lineage 3. We therefore studied in vitro growth rate in liquid broth,
intracellular growth rate in monocyte derived macrophages and
early pro-inflammatory cytokine induction by strains from each of
these different lineages.
Materials and Methods
Ethics statement
The study was conducted with ethical approval from the Faculty
of Health Sciences research ethics committee, University of Cape
Town (Reference 261/2008).
Selection of M. tuberculosis strains
We selected strains of M. tuberculosis from a previously described
collection of isolates from children from the broader Cape Town
region of South Africa [6]. Strains from children with tuberculosis
are likely to be representative of circulating M. tuberculosis strains in
the region, as childhood tuberculosis classically follows exposure to
an infectious adult source case. We performed spoligotyping and
multiple interspersed repetitive unit-variable number tandem
repeat (MIRU-VNTR) analysis in order to identify the major
strain lineages and strain clusters (Table 1). We selected strains
from the major clusters within each of the most common lineages
in this strain collection, including three lineage 2 (Beijing) strains
(two from the RD181, RD150 sublineage and one from the
RD181 sublineage) [25] and three lineage 4 (LAM3/F11) strains.
In addition, we selected two lineage 3 (CAS) strains, the previously
described CH strain as well as a second lineage 3 strain from the
Cape Town paediatric collection. H37Rv was used in all assays as
a reference strain.
Preparation of mycobacterial culture
To ensure a synchronous growth phase amongst all strains, M.
tuberculosis was grown at 37uC in a shaking incubator (120 rpm) to
mid log phase (0.6 to 0.9 OD) in Middlebrook 7H9 broth (Difco,
Detroit, MI, USA) containing 0.2% glycerol, 0.05% Tween 80,
and 10% albumin-dextrose-catalase (ADC) growth enrichment
(Becton Dickinson, Cockeysville, MD, USA). Multiple vials were
stored at 280uC until further use. A new vial of bacilli was thawed
before each experimental procedure. The colony forming unit
(CFU) concentration of stock vials was calculated by serial dilution
and plating in multiple replicates on Middlebrook 7H11 agar
(Difco, Detroit, MI, USA) containing 0.5% glycerol and 10% oleic
acid-albumin-dextrose-catalase (OADC) growth enrichment (Bec-
ton Dickinson, Cockysville, MD, USA).
Axenic growth assays M. tuberculosis growth in liquid
7H9 broth
For growth in axenic media, frozen stock of known CFU
concentration were freshly thawed and multiple replicates of
105 CFU/ml of bacilli of M. tuberculosis were inoculated into pre-
warmed 7H9 Middlebrook broth supplemented with .2% of
glycerol, .05% Tween 80, and 10% ADC growth enrichment and
cultured in a shaking incubator (120 rpm) at 37uC for 360 h. To
determine growth rate, aliquots were withdrawn at intervals and
plated for CFU enumeration by serial dilution and plating in
multiple replicates onto 7H11 agar containing 10% OADC.
Table 1. Genotype of selected M. tuberculosis strains.
Strain MIRU-VNTR Spoligotype Genotype
H37Rv 243132253233552 777777477760771 Lineage 4, Laboratory
strain
RXH248 442335464485372 000000000003771 Lineage 2, Beijing
RXH24 442345553575482 000000000003771 Lineage 2, Beijing
RXH360 442325554475472 000000000003771 Lineage 2, Beijing
CH 522355424275384 703777740003731 Lineage 3, CAS2
RXH379 4423664?? 285373 702777740003771 Lineage 3, CAS1
RXH266 442344442253172 774177407760771 Lineage 4, LAM3
RXH202 442344442253172 776177607760740 Lineage 4, LAM3
RXH6 442365542253173 774377007760771 Lineage 4, LAM3
doi:10.1371/journal.pone.0043170.t001
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Monocyte isolation, culture and maturation to monocyte
derived macrophages (MDM)
MDM were prepared from healthy donor buffy coats supplied
by South African Blood Transfusion Services. Peripheral blood
mononuclear cells (PBMC) were separated by centrifugation over
Ficol-paque Plus (Pharmacia, Uppsala, Sweden). Cells were
washed in RPMI, pooled and counted. Cells were incubated in
large tissue culture flask (175 cm2) at 3006106 PBMC per 25 ml
RPMI per flask for 2 hours at 37uC in 5% CO2. This step allows
monocytes to adhere to the flask. Non-adherent cells were
removed by three washes with 10 ml of pre-warmed RPMI
medium (Sigma-Aldrich, Ayrshire, UK). Finally, 10 ml of ice-cold
phosphate buffered saline (PBS) was added and the flask incubated
at 4uC for 20 minutes. Using a long handled scraper, monocytes
were dislodged from the bottom of the flask and pooled in a 50 ml
falcon tube for counting. Cells were plated in R10 medium (RPMI
containing 10% foetal calf serum (FCS)) at a concentration of
26105 cells/well in a 96 well tissue culture plate and cultured at
37uC, in 5% CO2, for 6 days in R10 medium to mature into
macrophages.
MDM infection and intracellular growth assay
For the intracellular growth assay, frozen M. tuberculosis stock
were freshly thawed and reconstituted at room temperature at the
time of infection. Before infection, each stock vial was plated for
CFU enumeration to reconfirm the standard concentration of the
inoculum. Adherent MDM were co-cultured in duplicate with
bacilli at 1:1 ratio in R10 medium (RPMI+ non heat-inactivated
10% FCS). After 4 h of incubation, extracellular bacteria were
removed gently by washing four times with pre-warmed PBS.
After 4, 24, 48 or 96 hours infected MDM were subjected to
complete lysis by mixing with 100 ml of 0.1% SDS and incubated
at room temperature for 12 mins. Lysates were mixed thoroughly
for ten times, serially diluted, and plated, in triplicate, on 7H11
agar plates. Plates were incubated for 3–4 weeks at 37uC and CFU
enumerated.
Cytokine Analysis
Culture supernatants from control and infected MDM cells
were harvested after 48 h and frozen at 280uC. Sterile-filtered
culture supernatants were assayed using an enzyme-linked
immunosorbent assay (ELISA) kit according to manufacturer’s
instructions (BD Biosciences Pharmingen, San Diego, CA, USA)
to measures levels of tumor necrosis factor (TNF) and IL12p40.
Statistical analysis
Graphpad Prism 5.00 was used for statistical analysis of
intracellular growth in monocyte derived macrophages and
cytokine assay. The intracellular growth index in MDM infection
was compared amongst strains from different groups using the
unpaired t test at each time point. Cytokines were analysed using
the non-paramatric Mann Whitney test. Axenic growth curve
analysis was performed with one-way ANOVA and Bonferroni’s
post hoc test.
Results
Mycobacterial growth in broth
M. tuberculosis strains belonging to different M. tuberculosis
lineages were grown in liquid 7H9 Middlebrook broth to evaluate
the growth rate amongst different lineages in axenic media (two
independent cultures, each performed in triplicate) (Fig. 1A and
1B). We used Cmax and Tmax to compare growth of various strains.
Cmax is defined as the peak point on the bacterial growth curve
(maximum number of colony forming units) whilst Tmax is the time
required to reach Cmax. H37Rv grew to a higher Cmax than
clinical strains (Table 2). Lineage 4 strains showed a higher Cmax
than clinical strains from other lineages. (Fig. 1C) lineage 2 strains
showed an intermediate level of growth whilst lineage 3 strains had
the lowest Cmax (Cmax, H37Rv vs lineage 4/lineage 2/lineage 3 all
p,0.0001; lineage 4 vs lineage 2 p= 0.0024; lineage 4 vs lineage 3
p= 0.0005). Tmax for H37Rv was 288 h. Lineage 3 strains showed
significantly shorter Tmax than H37Rv (p,0.05) (Fig. 1D).
Mycobacterial growth in the monocyte derived
macrophage model
We used the MDM infection model to evaluate differences in
intracellular growth in different donors (n = 7). We determined
initial strain uptake (after 4 h) by expressing the number of CFU at
the 4 hour time point from MDM lysates as a percentage of the
initial inoculum (Fig. 2). H37Rv showed lower strain uptake by
MDM than the clinical strains tested (p,0.001). There were no
significant differences in strain uptake between clinical strains.
To compare intracellular growth amongst different strain
lineages, we determined a growth index, calculated from the
log10 of number of CFU at each time point divided by the log10 of
number of CFU at the 4 h time point. Growth of all clinical strains
was slow for the first 24 hours. Lineage 2 and lineage 4 strains
grew faster over the first 48 hours than lineage 3 strains (lineage 3
vs. lineage 4 : p,0.01, lineage 3 vs. lineage 4: p,0.001). lineage 2
strains grew significantly faster than lineage 3 strains (p,0.01) over
96 hours (the mean growth index of lineage 4, lineage 2, lineage 3
and H37Rv was 1.196.22, 1.256.17, 1.116.10 and 1.696.13
respectively over 96 hours) (Fig. 3). Despite low initial uptake,
H37Rv multiplied more rapidly in MDM than clinical strains
(H37Rv vs. lineage 2 and lineage 4: p,0.001 at 24 h and 96 h,
H37Rv vs. lineage 3 : p,0.001 at all time points). As an
alternative approach to compare the growth rate amongst these
strains, we have also determined the doubling time of these strains
(Doubling time was calculated based on the mean numbers of
CFU at 4 hours and 96 hour) (Table 3). The mean doubling time
of lineage 2 strains was 23.3463.0 h, lineage 4 strains
25.1064.67 h, lineage 3 strains 26.1462.45 h and H37Rv
17.1261.61 h (mean 6 SD) over the 96 hour time period.
Cytokine induction
We investigated the release of TNF (n= 8 donors) and IL-12p40
(n= 6 donors) from monocyte-derived macrophages (MDM)
during 48 hours of infection with M. tuberculosis strains of various
lineages at 48 hours (Fig. 4). Lineage 2 and lineage 3 strains
induced lower levels of IL-12p40 when compared to H37Rv
(H37Rv: 385639.89 pg/ml, lineage 2: 91617.85 89 pg/ml,
lineage 3: 123.8610.1589 pg/ml, median 6 S.E, p,0.001) and
lineage 4 strains (lineage 4: 205614.84 pg/ml, median 6 S.E,
p,0.001) (Fig. 4A). Further, the release of TNF by MDM infected
with lineage 2 strains was significantly reduced when compared to
H37Rv (H37Rv: 1253683.52 pg/ml, lineage 2: 362627.58 pg/
ml, median 6 S.E, p,0.01) and other lineages (lineage 3:
18186123 pg/ml, lineage 4: 12076112 pg/ml, median 6 S.E,
p,0.001). In contrast to IL-12p40, higher levels of TNF were
induced by lineage 3 strains when compared to H37Rv (p,0.01)
and lineage 4 strains (p,0.05). Induction of both TNF and IL-
12p40 by lineage 4 strains was similar to that induced by H37Rv.
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Discussion
In this study, we compared lineage-specific in vitro phenotypes of
the two prevalent strain lineages from the Western Cape region of
South Africa with those of the laboratory strain H37Rv as well as
strains from lineage 3. We assessed two virulence-associated
characteristics in our study: mycobacterial growth (in liquid broth
and MDM) and proinflammatory cytokine induction in MDM.
We clearly demonstrated lineage-specific patterns of growth and
cytokine induction.
The laboratory-reference strain H37Rv grew most rapidly in
liquid culture, suggesting that H37Rv is highly adapted to
laboratory media. Interestingly, there were clear lineage-specific
differences in growth patterns in axenic media, with lineage 4
strains reaching a higher Cmax than the other two lineages and
lineage 3 strains peaking early at a lower Cmax. Lineage 2 strains
had an intermediate phenotype. Our results are in line with
previous findings which showed slow growth of lineage 3 (CAS
strain) in 7H9 broth [19,22].
Several previous studies have assessed intracellular growth of M.
tuberculosis in human macrophages as a marker of virulence
[13,15,26,27]. Individual strains from lineage 2 (Beijing) have been
shown to grow more rapidly than comparator strains in in vitro
human cell culture models using MDM or monocyte or human
macophage cell lines [13,14,15]. Zhang et al utilized the monocyte
derived macrophage model to study the correlation between the
extent of the spread of M. tuberculosis strains in a Los Angeles
Figure 1. Growth of M. tuberculosis strains in liquid 7H9 broth. Fig. 1 (A) Growth of individual M. tuberculosis strains from different lineages in
liquid 7H9 broth. Data represent the mean and range (n = 2) values. Fig. 1 (B) Summarized growth of M. tuberculosis strain lineages. Fig. 1 (C)
Comparison of Cmax (maximum point on the growth curve) for different strain lineages. Lineage 4 strains showed higher Cmax than lineage
2**(p = 0.01) and lineage 3*** strains (p = 0.001). H37Rv showed significantly higher Cmax than all clinical strains
# (p = 0.001) Fig. 1 (D) Comparison of
Tmax (time to reach to Cmax) for different strain lineages. H37Rv reached Tmax significantly faster than lineage 3 strains* (p = 0.05).
doi:10.1371/journal.pone.0043170.g001
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community setting and the ability of the strains to grow in human
macrophages. Multiple isolates of M. tuberculosis strain 210 (a
Beijing-family strain [lineage 2] responsible for an outbreak in Los
Angeles), grew more rapidly than small cluster or unique cluster
strains in human MDM [14]. In contrast Shon et al found no
significant difference in growth of a hypervirulent Beijing strain
(K-strain) [lineage 2] from Korea compared with H37Rv in
murine bone marrow derived macrophages [18].
We found that lineage 2 and lineage 4 strains grew more rapidly
than lineage 3 strains during the first 48 hours but that growth
declined over the next 48 h. In contrast, H37Rv continued to
grow more rapidly than all clinical strains. Initial uptake by MDM
was lowest for H37Rv, but similar for all clinical strains. There is
evidence of variation in phagocytosis by different strains [28]. For
example Schlesinger et al found that phagocytosis of two virulent
strains (H37Rv and Erdman) by human monocyte derived
macrophages is mediated by the mannose receptor in addition
to complement receptor (CR1, CR3 and CR4) whereas the
avirulent strain H37Ra uses only complement receptor for
phagocytosis [29]. It is unclear whether the differential uptake
which we demonstrated is due to differential expression of such
pathogen-associated molecular patterns.
There are a number of limitations of this in vitro model. Short
term growth in macrophages only partially reflects the more
lengthy and complex pathogenesis in humans, we were unable to
distinguish bacterial uptake from simple adherence to macro-
phages and PBMC-derived macrophages differ phenotypically
from alveolar macrophages [30]. Rapid growth in macrophages
may not necessarily represent a virulence characteristic [18].
Furthermore, due to the limited number of MDM available, we
were only able to compare a few strains from each lineage. All of
these strains (except CH) were isolated from South African
patients, and only represent specific sub-lineages. They do not
therefore represent the global diversity of ‘modern’ TB strains.
Early proinflamatory cytokine secretion is a hallmark of M.
tuberculosis infection. IL-12 production is essential to induce a
protective Th1 response [31]. In humans, mutations in the IL-
12p40 and the IL-12 receptor genes result in enhanced
Table 2. Strain wise comparison of M. tuberculosis growth in
axenic media based on Cmax # and Tmax # # values.
Strain Lineage Cmax (CFU/ml) Tmax (h)
H37Rv Laboratory strain 5.1460.686108 288
RXH24 Lineage 2 4.5060.026108 204
RXH248 Lineage 2 5.3361.46107 288
RXH360 Lineage 2 9.0762.76107 264
CH Lineage 3 1.6960.346107 216
RXH379 Lineage 3 3.6860.976107 180
RXH202 Lineage 4 1.4460.0826108 240
RXH266 Lineage 4 1.4660.296108 252
RXH6 Lineage 4 2.1060.706108 240
#Cmax : maximum number of colony forming units,
# #Tmax : Time required to reach Cmax. Data represent mean 6 SD obtained
from two separate growth experiments.
doi:10.1371/journal.pone.0043170.t002
Figure 2. Strain uptake by monocyte derived macrophages. Fig. 2 (A) Uptake of M. tuberculosis strains by MDM (4 h CFU calculated as a
percentage of initial inoculum). Fig. 2 (B) Summarized uptake of M. tuberculosis strain lineages by MDM. H37Rv showed significantly lower uptake by
the than clinical strains# (p,0.001). Data represent the mean 6 SD (n = 7).
doi:10.1371/journal.pone.0043170.g002
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susceptibility to mycobacterial infection [32,33]. TNF is produced
by monocytes and macrophages in early infection and plays a key
role in protective immunity during tuberculosis infection. In
humans, neutralization of TNF using anti-TNF drugs increases the
risk of reactivation of latent tuberculosis [34,35,36]. Hirsch et al.
showed that TNF inhibits the growth of M. tuberculosis within
alveolar macrophages [37].
Several studies have reported that heterogeneity exists in the
cytokine response induced by various genotype of M. tuberculosis
[20,22]. Modern lineages (lineage 2, lineage 3 and lineage 4) were
shown to induce lower levels of proinflamatory cytokines when
compared with ancient lineages (lineage 1, lineage 5 and lineage 6)
[38]. Lineage 4, a modern M. tuberculosis lineage, consists of a
diverse group of M. tuberculosis strains. Haarlem and LAM strains
belonging to this lineage induced similar level of TNF, IL-6, IL-10
and GRO-a as H37Rv in human macrophages [20]. Another
outbreak strain, CDC1551, which is a representative of lineage 4
(belonging to the X family) induces high levels of pro-inflamma-
tory cytokines in monocyte culture [39,40]. We studied only
modern lineages of M. tuberculosis and were able to demonstrate
distinct patterns of cytokine induction by representatives of the
three major modern strain lineages. Lineage 4 (LAM3) strains
induced similar levels of cytokine to the reference strain H37Rv.
Lineage 3 strains have been reported to either induce similar levels
of proinflammatory cytokines to lineage 2 strains (low levels) or to
induce similar levels to H37Rv (higher levels) [19,20,22]. Our
findings are in line with those of Newton and colleagues [22] who
described high TNF and low IL-12p40 secretion by MDM
infected by a lineage 3 strain.
A recent study has demonstrated that ancient Beijing strains
(lineage 2) from Brazil (characterized by the absence of an
insertion sequence 6110 within the noise transfer function region)
induced similar levels of TNF and IL-10 to H37Rv whilst modern
MDR Beijing strains (lineage 2) isolated in Russia, induced low
TNF and high IL-10 in the THP1 macrophage cell line [41]. In
contrast, another study has found that Beijing strains (lineage 2),
irrespective of subfamily, showed an immune phenotype of low
level of TNF, IL-6, IL-10 and GRO-a [20] production as
compared to H37Rv and other genotypes of M. tuberculosis in
human macrophages. Low proinflamatory cytokine induction by
lineage 2 (Beijing strains) has been repeatedly reported in various
human cell culture models including human monocyte-derived
macrophages and the THP1 cell line [14,17,18,19,20,41]. Our
results, with selected modern Beijing strains from South Africa are
consistent with other studies showing low levels of proinflamatory
cytokine secretion by infected human MDM.
In summary, we have demonstrated that different modern M.
tuberculosis lineages exhibit lineage-specific patterns of IL12p40 and
TNF induction, with lineage 4 strains inducing high levels of both
cytokines, lineage 2 strains low levels of both cytokines and lineage
3 strains high levels of TNF but low levels of IL12p40. This study
suggests that modern strain lineages of M. tuberculosis may possess
lineage-specific patterns of growth and cytokine induction. These
in vitro characteristics may reflect different strategies that M.
Figure 3. Growth index reflecting the intracellular growth of M. tuberculosis strains in MDM. Fig. (3A) Growth index of M. tuberculosis
strains (calculated by the CFU at each time point divided by the CFU at initial time point). Fig. (3B) Summarized growth index of M. tuberculosis strain
lineages. Data represent the mean 6 SD (n = 7). Statistical significance is denoted as *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0043170.g003
Table 3. Doubling time+ for M. tuberculosis strains from
different lineages in human monocyte derived macrophages.
Strain Lineage 24 hrs 48 hrs 96 hrs
H37Rv Lab strain 13.7162.17 13.1661.44 17.1261.61
RXH24 Lineage 2 17.2362.59 14.4161.59 22.8562.11
RXH360 Lineage 2 38.99613.2 16.3161.82 23.4762.11
RXH248 Lineage 2 25.7862.71 13.5261.53 23.7262.10
CH Lineage 3 44.9768.9 29.7963.75 25.6062.09
RXH379 Lineage 3 20.9363.05 19.7262.18 26.6962.08
RXH202 Lineage 4 35.1467.45 18.9262.8 23.1462.26
RXH266 Lineage 4 24.4864.08 14.2161.57 23.0362.05
RXH6 Lineage 4 36.3769.91 17.6661.81 29.0362.59
+Doubling times = t/3.3 log (b/B) (t = time, B = initial colonies, b = final colonies).
Data represent means 6 S.D from n=7 donors.
doi:10.1371/journal.pone.0043170.t003
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tuberculosis employs to exploit ecological niches in different human
populations.
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